# NPLATE
> **BLA125268** · Biologics License Application · Sponsor: AMGEN · Approved 2008-08-22
## Drug
- **FDA Application Number:** BLA125268
- **Application type:** Biologics License Application
- **Brand name:** NPLATE
- **Generic name:** ROMIPLOSTIM
- **Active ingredients:** ROMIPLOSTIM
- **Dosage form:** INJECTABLE
- **Route:** SUBCUTANEOUS
- **Marketing status:** Prescription
- **Sponsor:** AMGEN
- **Manufacturer:** Amgen, Inc
- **First approval:** 2008-08-22
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125268)
---
*AI Analytics · CC0 1.0*